If you have wet age-related macular degeneration (wet AMD) or another disease of the retina, your doctor may recommend treatment with an anti-VEGF drug. VEGF, or vascular endothelial growth factor, is ...
CHICAGO — The number of injections required for the successful treatment of neovascular age-related macular degeneration could be reduced considerably with experimental therapies, new research shows.
An injection that helps to block the growth of abnormal blood vessels in the back of the eye in patients with wet age-related macular degeneration (AMD) is set to become available on the NHS in ...
WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...
What Is Eylea, and Why Does It Matter? Eylea HD (aflibercept) is an injectable prescription medicine used for treating certain eye conditions that can cause vision loss over time. The FDA has now ...
Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...
Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. One intravitreal injection of 4D-150 helped reduce the ...
According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results